This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2016 Oct;17(10):e420.

doi: 10.1016/S1470-2045(16)30440-5. Epub 2016 Sep 1.

Correction to Lancet Oncol 2016; 17: 1426

No authors listed

PMID: 27592806
DOI: 10.1016/S1470-2045(16)30440-5

Published Erratum

Correction to Lancet Oncol 2016; 17: 1426

No authors listed. Lancet Oncol. 2016 Oct.

. 2016 Oct;17(10):e420.

doi: 10.1016/S1470-2045(16)30440-5. Epub 2016 Sep 1.

PMID: 27592806
DOI: 10.1016/S1470-2045(16)30440-5

No abstract available

PubMed Disclaimer

Erratum for

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial.
Stintzing S, Modest DP, Rossius L, Lerch MM, von Weikersthal LF, Decker T, Kiani A, Vehling-Kaiser U, Al-Batran SE, Heintges T, Lerchenmüller C, Kahl C, Seipelt G, Kullmann F, Stauch M, Scheithauer W, Held S, Giessen-Jung C, Moehler M, Jagenburg A, Kirchner T, Jung A, Heinemann V; FIRE-3 investigators. Stintzing S, et al. Lancet Oncol. 2016 Oct;17(10):1426-1434. doi: 10.1016/S1470-2045(16)30269-8. Epub 2016 Aug 27. Lancet Oncol. 2016. PMID: 27575024 Clinical Trial.

Similar articles

Correction to Lancet Oncol 2022; 23 (Abstracts from the The Lancet Summit: Cancer care in Asia and Latin America Special Issue): S11.
[No authors listed] [No authors listed] Lancet Oncol. 2022 Jul 20:S1470-2045(22)00485-5. doi: 10.1016/S1470-2045(22)00485-5. Online ahead of print. Lancet Oncol. 2022. PMID: 35870470 No abstract available.
Correction to Lancet Oncol 2016; 17: 1482.
[No authors listed] [No authors listed] Lancet Oncol. 2016 Dec;17(12):e519. doi: 10.1016/S1470-2045(16)30596-4. Lancet Oncol. 2016. PMID: 27924750 No abstract available.
Correction to Lancet Oncol 2016; 17: 1426-34.
[No authors listed] [No authors listed] Lancet Oncol. 2016 Nov;17(11):e479. doi: 10.1016/S1470-2045(16)30514-9. Lancet Oncol. 2016. PMID: 27819245 No abstract available.
Correction to Lancet Oncol 2016; 17: 431, 434, 435.
[No authors listed] [No authors listed] Lancet Oncol. 2016 Jul;17(7):e270. doi: 10.1016/S1470-2045(16)30222-4. Epub 2016 Jun 28. Lancet Oncol. 2016. PMID: 27733295 No abstract available.
Correction to Lancet Oncol 2016; 17: 888, 890, 892.
[No authors listed] [No authors listed] Lancet Oncol. 2016 Jul;17(7):e270. doi: 10.1016/S1470-2045(16)30221-2. Epub 2016 Jun 28. Lancet Oncol. 2016. PMID: 27733294 No abstract available.

See all similar articles

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations